Jianmin Pharmaceutical Group Co.,Ltd.

SHSE:600976 주식 보고서

시가총액: CN¥6.5b

Jianmin Pharmaceutical GroupLtd 관리

관리 기준 확인 3/4

Jianmin Pharmaceutical GroupLtd CEO는 Jun Wang, Sep2022 에 임명되었습니다 의 임기는 2.17 년입니다. 는 CN¥ 14.73M 가치에 해당하는 회사 주식의 0.23% 직접 소유합니다. 14.73M. 경영진과 이사회의 평균 재임 기간은 각각 2.2 년과 2.2 년입니다.

주요 정보

Jun Wang

최고 경영자

CN¥891.4k

총 보상

CEO 급여 비율n/a
CEO 임기2.2yrs
CEO 소유권0.2%
경영진 평균 재임 기간2.2yrs
이사회 평균 재임 기간2.2yrs

최근 관리 업데이트

Recent updates

Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

Nov 10
Potential Upside For Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976) Not Without Risk

If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Sep 25
If EPS Growth Is Important To You, Jianmin Pharmaceutical GroupLtd (SHSE:600976) Presents An Opportunity

Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

Aug 25
Calculating The Fair Value Of Jianmin Pharmaceutical Group Co.,Ltd. (SHSE:600976)

The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

Jul 12
The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

Jun 30
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

May 21
We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Apr 26
We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

CEO

Jun Wang (47 yo)

2.2yrs

테뉴어

CN¥891,400

보상

Mr. Jun Wang was Vice President of KPC Pharmaceuticals,Inc until September 08, 2020. He is Managing Director of Jianmin Pharmaceutical Group Co.,Ltd. He is Director and President of Jianmin Pharmaceutical...


리더십 팀

이름위치테뉴어보상소유권
Jun Wang
President2.2yrsCN¥891.40k0.23%
CN¥ 14.7m
Chaoyang Cheng
Financial Director2.2yrsCN¥511.20k0.055%
CN¥ 3.6m
Zhenbo Hu
VP & Director1.3yrsCN¥210.40k데이터 없음
Jie Zhou
Secretary2.2yrsCN¥408.80k0.024%
CN¥ 1.6m
Xuejun Pei
Vice President2.2yrsCN¥540.00k0.12%
CN¥ 7.8m
Zhijun Huang
Vice President2.2yrsCN¥540.00k0.11%
CN¥ 6.9m

2.2yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: 600976 의 관리팀은 경험 ( 2.2 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Jun Wang
President2.2yrsCN¥891.40k0.23%
CN¥ 14.7m
Zhenbo Hu
VP & Director1.3yrsCN¥210.40k데이터 없음
Qin He
Chairman2.2yrsCN¥2.10m0.27%
CN¥ 17.4m
Qijing Xiao
Chairman of the Supervisory Board2.2yrs데이터 없음데이터 없음
Yunpei Guo
Independent Director2.2yrsCN¥90.00k데이터 없음
Rong Pei
Director2.2yrsCN¥60.00k데이터 없음
Liang Xu
Director2.2yrsCN¥60.00k데이터 없음
Shuqu Li
Independent Director2.2yrsCN¥90.00k데이터 없음
Hu Jian
Supervisor2.2yrs데이터 없음데이터 없음
Li Chen
Supervisor2.2yrs데이터 없음데이터 없음
Jingqiu Tang
Supervisor2.2yrs데이터 없음데이터 없음
Zhi Yang
Independent Director2.2yrsCN¥90.00k데이터 없음

2.2yrs

평균 재임 기간

53.5yo

평균 연령

경험이 풍부한 이사회: 600976 의 이사회경험(평균 재직 기간 2.2 년)으로 간주되지 않으므로 새 이사회가 필요합니다.